Saturday, October 16, 2021
Home Tags Clinical trials

clinical trials Related News

Forxiga could transform treatment for chronic kidney disease

Forxiga could transform treatment for chronic kidney disease

AstraZeneca’s Forxiga has been recommended for approval in the European Union for the treatment of chronic kidney disease in adults with and without Type 2 diabetes. The...
virtual

Clinical trial using virtual populations proves successful

Using virtual subjects for clinical trials can be as effective as using real patients, the results of a recent study have shown. In an evaluation...
AstraZeneca treatment unsuccessful at preventing symptomatic COVID-19

AstraZeneca treatment unsuccessful at preventing symptomatic COVID-19

AstraZeneca’s antibody treatment – AZD7442 – has been unsuccessful in preventing symptomatic COVID-19 in patients recently exposed to the SARS-CoV-2 virus. The results of AstraZeneca’s...
Positive patient reported outcomes for prostate cancer therapy

Positive patient reported outcomes for prostate cancer therapy

Results from the Phase III TITAN study final analysis have confirmed the survival benefit achieved with the addition of apalutamide to androgen deprivation therapy...
World’s first COVID-19 vaccine booster clinical trial begins

World’s first COVID-19 vaccine booster clinical trial begins

The world’s first clinical trial looking at seven different COVID-19 booster vaccines has begun in the UK, with initial results expected in September. As part...
Medicinal cannabis research gets $1.5m for cancer treatment symptoms

Medicinal cannabis research gets $1.5m for cancer treatment symptoms

A new University of Adelaide trial will explore the use of personalised medicinal cannabis dosing to prevent common and impactful symptoms of treatment in...
World-first major progressive multiple sclerosis trial to launch in UK

World-first major progressive multiple sclerosis trial to launch in UK

The world’s first meg-trial for progressive multiple sclerosis (MS) is to launch later this year in the UK. The Octopus trial is a revolutionary clinical...
Gamechanger drug for psoriasis treatment offers hope for patients

Gamechanger drug for psoriasis treatment offers hope for patients

A novel drug has shown promise for patients after almost entirely clearing moderate to severe psoriasis in over 60% of clinical trial participants. The trials...
Clinical trial launched for Type 1 Diabetes medication

Clinical trial launched for Type 1 Diabetes medication

A Phase II clinical trial that will test the efficacy of a medication for Type 1 Diabetes has been initiated. Adocia, a clinical stage biopharmaceutical...
Spincare study shows promising results for treating wounds and burns

Spincare study shows promising results for treating wounds and burns

A new clinical study has demonstrated the effectiveness of Nanomedic’s Spincare System for the treatment of wounds and burns. Nanomedic Technologies, a leader in Electrospun...
TB vaccine could protect babies against new infectious diseases

TB vaccine could protect babies against new infectious diseases

A new study has shown that a tuberculosis (TB) vaccine could help to protect newborn babies against a number of different infectious diseases –...
Lifesaving COVID-19 treatment for hospitalised UK patients

Lifesaving COVID-19 treatment for hospitalised UK patients

Thousands of NHS patients who need to be hospitalised due to COVID-19 will now be able to receive a life-saving treatment named tocilizumab. Clinical trials...
Clinical trial to test treatment for recent onset Type 1 Diabetes

Clinical trial to test treatment for recent onset Type 1 Diabetes

A clinical trial will test the efficacy of the treatment IMCY-0098 in patients with recent onset Type 1 Diabetes. Imcyse, a clinical-stage biopharmaceutical company pioneering...
Single-dose Janssen COVID-19 vaccine shows 66% effectiveness

Single-dose Janssen COVID-19 vaccine shows 66% effectiveness

New data from the Phase III studies of Janssen’s single-dose COVID-19 vaccine candidate has shown 66% effectiveness in preventing coronavirus in participants. The UK has...
Novavax COVID-19 vaccine shows efficacy against Kent variant

Novavax COVID-19 vaccine shows efficacy against Kent variant

Novavax has released data from its phase III COVID-19 vaccine candidate study that demonstrates it as effective against the Kent variant of the virus. Conducted...
Reducing cardiovascular and cerebrovascular deaths with AstraZeneca

Reducing cardiovascular and cerebrovascular deaths with AstraZeneca

AstraZeneca’s recent THALES Phase III trial has demonstrated the efficacy of the drug Brilinta for reducing the risk of major cardiovascular events such as...
Study explores umbilical cord-derived stem cell COVID-19 treatment

Study explores umbilical cord-derived stem cell COVID-19 treatment

A groundbreaking, randomised controlled trial has shown that umbilical cord-derived mesenchymal stem cell infusions safely reduce risk of death and aid quicker recovery in...
Pregnant women excluded from three quarters of COVID-19 trials

Pregnant women excluded from three quarters of COVID-19 trials

New data has shown that pregnant women are being excluded from three quarters of COVID-19 treatment trials despite being one of the most in-need...
COVID-19 pandemic risks global health infrastructure

COVID-19 pandemic risks global health infrastructure

A new report has found that the COVID-19 pandemic is putting health infrastructure around the world at risk. The report, released by the non-profit Global...
Pritelivir phase III clinical trials for HSV immunocompromised patients

Pritelivir Phase III clinical trials for HSV immunocompromised patients

The medicine Pritelivir is to enter Phase III clinical trials for the treatment of immunocompromised patients who have acyclovir-resistant mucocutaneous herpes simplex virus (HSV)...

Health Special Reports

Health eBooks

Health Partners

Pin It on Pinterest